Page last updated: 2024-08-18

acrolein and Parkinson Disease

acrolein has been researched along with Parkinson Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acosta, G; Ambaw, A; Herr, SA; Hubers, SA; Liu, F; Pond, A; Rochet, JC; Shi, R; Strathearn, KE; Tambe, MA; Tang, J; Truong, A; Walls, E; Zheng, L1
Ameenuddin, S; Citron, BA; Festoff, BW; SantaCruz, K; Suo, WZ; Uchida, K1
Abuladze, N; Bragin, A; Cascio, D; Damoiseaux, R; Faull, K; Pushkin, A; Schibler, MJ; Tsirulnikov, K1
Hashizume, Y; Maruyama, W; Naoi, M; Osawa, T; Riederer, P; Shamoto-Nagai, M; Yoshida, M1

Other Studies

4 other study(ies) available for acrolein and Parkinson Disease

ArticleYear
Acrolein-mediated neuronal cell death and alpha-synuclein aggregation: Implications for Parkinson's disease.
    Molecular and cellular neurosciences, 2018, Volume: 88

    Topics: Acrolein; alpha-Synuclein; Animals; Cell Death; Cell Line; Dopamine; Dopaminergic Neurons; Oxidative Stress; Parkinson Disease; Rats; Spinal Cord Injuries; Substantia Nigra

2018
Membrane lipid peroxidation in neurodegeneration: Role of thrombin and proteinase-activated receptor-1.
    Brain research, 2016, 07-15, Volume: 1643

    Topics: Acrolein; Aldehydes; Alzheimer Disease; Animals; Cells, Cultured; Cytoplasm; Dose-Response Relationship, Drug; Humans; Lipid Peroxidation; Membrane Lipids; Mice; Motor Neurons; Parkinson Disease; Receptor, PAR-1; Thrombin

2016
Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal.
    Toxicology and applied pharmacology, 2012, Sep-15, Volume: 263, Issue:3

    Topics: Acetylation; Acetylcysteine; Acrolein; Aldehydes; Alzheimer Disease; Amidohydrolases; Aminooxyacetic Acid; Animals; Cerebral Cortex; Enzyme Inhibitors; Male; Neurons; Parkinson Disease; Rats; Rats, Wistar

2012
In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity.
    Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:12

    Topics: Acrolein; Aged; alpha-Synuclein; Blotting, Western; Dopamine; Electrophoresis, Polyacrylamide Gel; Female; Humans; Lipid Peroxidation; Male; Melanins; Neurons; Parkinson Disease; Proteasome Endopeptidase Complex; Substantia Nigra

2007